BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1402254)

  • 1. [Secondary leukemia and the countermeasures].
    Hirashima K
    Nihon Naika Gakkai Zasshi; 1992 Jul; 81(7):1070-5. PubMed ID: 1402254
    [No Abstract]   [Full Text] [Related]  

  • 2. The incidence of long-term side effects--in particular induced leukemias following treatment for Hodgkin's disease.
    De Renzis C; Cellini N; Ausili Cefaro GP; Mantini G; Parisi S; Smaniotto D
    Rays; 1986; 11(2):109-13. PubMed ID: 3602444
    [No Abstract]   [Full Text] [Related]  

  • 3. [Acute leukemia in patients treated for Hodgkin's disease].
    Boccaccio P; Rosa F; Casciaro S; D'Elia P; Romagnoli M; Ghio R
    Recenti Prog Med; 1988 Jan; 79(1):32-7. PubMed ID: 3375542
    [No Abstract]   [Full Text] [Related]  

  • 4. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cancers caused by therapeutic noxae: cancer and radiotherapy].
    Tubiana M
    Bull Cancer; 1983; 70(1):47-54. PubMed ID: 6839034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukemia risk in thorotrast patients.
    Boice JD
    Radiat Res; 1993 Nov; 136(2):301-2; author reply 303-4. PubMed ID: 8248491
    [No Abstract]   [Full Text] [Related]  

  • 7. [Acute non-lymphatic leukemia after treatment of Hodgkin's lymphoma with chemotherapy and radiotherapy].
    Lira P; Grebe G
    Rev Med Chil; 1984 Oct; 112(10):1021-5. PubMed ID: 6085597
    [No Abstract]   [Full Text] [Related]  

  • 8. Study of erythrocyte mean corpuscular volume during cytotoxic therapy as a predictive parameter of the risk of secondary leukemia in Hodgkin's disease.
    de Gramont A; Rioux E; Drolet Y; Delage JM
    Cancer Treat Rep; 1984 Dec; 68(12):1467-70. PubMed ID: 6509452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second neoplasms in Hodgkin's disease: current controversies.
    Zarrabi MH; Rosner F
    Hematol Oncol Clin North Am; 1989 Jun; 3(2):303-18. PubMed ID: 2663829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute myeloid leukemia following therapy of Hodgkin's disease with radiotherapy and ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine).
    Lipton JH; Gospodarowicz M; Reingold S
    Hematol Oncol; 1996 Mar; 14(1):29-31. PubMed ID: 8613133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical problems in radiation hematology].
    Bauer R
    Arztl Forsch; 1969 Apr; 23(4):139-46. PubMed ID: 5819112
    [No Abstract]   [Full Text] [Related]  

  • 12. Fifteen-year experience in Hodgkin's disease: role of combined modality treatment and splenectomy in the incidence of secondary acute leukemia.
    Zinzani PL; Fiacchini M; Mazza P; Gherlinzoni F; Bocchia M; Tura S
    Haematologica; 1991; 76(4):305-10. PubMed ID: 1724437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological follow-up studies of the Portuguese Thorotrast series (up-dated results).
    da Silva Horta J; Cayolla da Motta L; Tavares MH
    RISO Rep; 1973 Jun; (294):193-211. PubMed ID: 4549662
    [No Abstract]   [Full Text] [Related]  

  • 14. [Secondary leukemia].
    Urbańska-Ryś H; Robak T; Krykowski E
    Acta Haematol Pol; 1992; 23(2):71-7. PubMed ID: 1488863
    [No Abstract]   [Full Text] [Related]  

  • 15. Constitutional disorders of man predisposing to leukemia and lymphoma.
    Fraumeni JF
    Natl Cancer Inst Monogr; 1969 Aug; 32():221-32. PubMed ID: 4242594
    [No Abstract]   [Full Text] [Related]  

  • 16. Report on the German Thorotrast Study.
    van Kaick G; Muth H; Kaul A; Wesch H; Immich H; Liebermann D; Lorenz D; Lorenz WJ; Lührs H; Scheer KE
    Strahlentherapie Sonderb; 1985; 80():114-8. PubMed ID: 4095718
    [No Abstract]   [Full Text] [Related]  

  • 17. Leukemia and other hematological diseases after thorotrast.
    Faber M; Johansen C
    Ann N Y Acad Sci; 1967 Dec; 145(3):755-8. PubMed ID: 5239248
    [No Abstract]   [Full Text] [Related]  

  • 18. Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's disease.
    N Engl J Med; 1987 Sep; 317(11):707-9. PubMed ID: 3627177
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute leukemia after the treatment of Hodgkin's disease.
    Henry-Amar M; Dietrich PY
    Hematol Oncol Clin North Am; 1993 Apr; 7(2):369-87. PubMed ID: 8468271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acute non-lymphoblastic leukosis as a second neoplasm in Hodgkin's disease].
    Díaz Pérez MA; Zamora Auñón P; Escobar Alvarez Y; García de Parecdes ML
    Med Clin (Barc); 1985 Feb; 84(4):167. PubMed ID: 3982119
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.